Cargando…
Targeting RNA with small molecules: lessons learned from Xist RNA
Although more than 98% of the human genome is noncoding, nearly all drugs on the market target one of about 700 disease-related proteins. However, an increasing number of diseases are now being attributed to noncoding RNA and the ability to target them would vastly expand the chemical space for drug...
Autores principales: | Nickbarg, Elliott B., Spencer, Kerrie B., Mortison, Jonathan D., Lee, Jeannie T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019374/ https://www.ncbi.nlm.nih.gov/pubmed/36725318 http://dx.doi.org/10.1261/rna.079523.122 |
Ejemplares similares
-
Recognizing the power of machine learning and other computational methods to accelerate progress in small molecule targeting of RNA
por: Bagnolini, Greta, et al.
Publicado: (2023) -
Female mice lacking Xist RNA show partial dosage compensation and survive to term
por: Yang, Lin, et al.
Publicado: (2016) -
Retinoic acid accelerates downregulation of the Xist repressor, Oct4, and increases the likelihood of Xist activation when Tsix is deficient
por: Ahn, Janice Y, et al.
Publicado: (2010) -
Small molecules to target tau amyloid aggregation
por: Manglano-Artuñedo, Zoe, et al.
Publicado: (2023) -
Probing Xist RNA Structure in Cells Using Targeted Structure-Seq
por: Fang, Rui, et al.
Publicado: (2015)